LET’S WORK TOGETHER TO ADVANCE PSORIASIS LEADERSHIP TOWARDS A WORLD FREE OF PSORIASIS
Your donations help the IPC achieve our vision of a world free of psoriasis . We are a global network of over 100 psoriasis experts, thought leaders, and professionals, dedicated to improving patient care around the globe. We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.
You can support the IPC by providing unrestricted funds through our Corporate Membership program or by sponsoring one of our important education, research or patient care initiatives.
For more information on supporting the International Psoriasis Council, please contact Tina Burke, Corporate Relations Director Tina.Burke@psoriasiscouncil.org
Latest news Dermavant Announces FDA Approval for VTAMA® (Tapinarof) CreamMay 26, 2022Dermavant announced the FDA approval for VTAMA® (tapinarof) cream, 1% for the Treatment of Plaque Psoriasis in Adults. This is the first topical novel chemical entity launched for psoriasis in the U.S. in 25 years. Bristol Myers Squibb (BMS) Announces New Two-Year Deucravacitinib DataMay 16, 2022Bristol Myers Squibb (BMS) announced new two-year data that reinforces the durable efficacy and consistent safety profile of Deucravacitinib when used to treat moderate to severe plaque psoriasis. Commentary: Vaccine Hesitancy and Access to Psoriasis Care in the COVID-19 PandemicMay 11, 2022IPC Councilor, Ulrich Mrowietz, MD, shares his expert opinion on Cook et al (Br J Dermatol 2022 (online first)) report on the interruption of psoriasis care during the COVID-19 pandemic and vaccine hesitancy in patients with psoriasis. New Corporate MemberMay 03, 2022IPC is pleased to welcome AnaptysBio as a Bronze Level Corporate Member! More News